Clinical Trials on Conjunctivitis, Viral in New Zealand
Total 2615 results
-
AllerganCompletedAtopic ConjunctivitisCanada, Czech Republic, United States, Italy, Israel, New Zealand, Spain, India, Germany, Australia, France, United Kingdom
-
Alios Biopharma Inc.TerminatedHepatitis B | Chronic Hepatitis B | Viral Hepatitis BNew Zealand
-
Alios Biopharma Inc.Completed
-
Vertex Pharmaceuticals IncorporatedCompleted
-
Gilead SciencesCompleted
-
University of Auckland, New ZealandCompletedVaccinationNew Zealand
-
Assembly BiosciencesNot yet recruitingRecurrent Genital Herpes Simplex Type 2New Zealand
-
Gilead SciencesCompletedHepatitis C Virus InfectionNew Zealand
-
Enanta Pharmaceuticals, IncNovotech (Australia) Pty LimitedCompletedHepatitis CNew Zealand
-
Assembly BiosciencesCompletedChronic Hepatitis BNew Zealand
-
Janssen Research & Development, LLCTerminatedHealthy | Hepatitis B, ChronicNew Zealand
-
Akesobio Australia Pty LtdCompletedCoronavirus Disease 2019 (COVID-19)New Zealand
-
Bausch & Lomb IncorporatedCompletedAllergic ConjunctivitisUnited States
-
Hoffmann-La RocheCompletedHepatitis C, Chronic, Healthy VolunteerNew Zealand
-
Sutphin DrugsUnknownBlepharo ConjunctivitisUnited States
-
Novartis PharmaceuticalsTerminated
-
Jiangsu Rec-Biotechnology Co., Ltd.Iqvia Pty LtdCompleted
-
Starx Research Center, LLCUnknownAllergic Conjunctivitis | RhinoconjunctivitisUnited States
-
Gilead SciencesCompletedChronic Hepatitis CNew Zealand
-
Qilu Pharmaceutical Co., Ltd.Unknown
-
Gilead SciencesCompleted
-
Assembly BiosciencesCompletedChronic Hepatitis BNew Zealand
-
Antipodean Pharmaceuticals, Inc.Completed
-
Arbutus Biopharma CorporationRecruitingChronic Hepatitis bNew Zealand
-
Arrowhead PharmaceuticalsTerminated
-
Vertex Pharmaceuticals IncorporatedCompletedHepatitis C | Chronic Hepatitis C | HCV | CHCNew Zealand
-
Assembly BiosciencesCompleted
-
Enanta Pharmaceuticals, IncTerminatedChronic Hepatitis B Virus InfectionNew Zealand
-
Gilead SciencesCompleted
-
Bausch & Lomb IncorporatedTerminatedBacterial ConjunctivitisUnited States
-
Bausch & Lomb IncorporatedTerminatedBacterial ConjunctivitisUnited States
-
Bausch & Lomb IncorporatedCompletedBacterial ConjunctivitisUnited States
-
Bausch & Lomb IncorporatedCompletedConjunctivitis, AllergicUnited States
-
Bausch & Lomb IncorporatedCompletedBacterial ConjunctivitisUnited States
-
Gilead SciencesCompletedChronic Hepatitis C InfectionNew Zealand
-
Vistakon PharmaceuticalsCompletedAllergic ConjunctivitisUnited States
-
Virion TherapeuticsRecruitingChronic Hepatitis BHong Kong, New Zealand
-
Novira Therapeutics, Inc.CompletedChronic Hepatitis BNew Zealand
-
Aligos TherapeuticsTerminatedChronic Hepatitis BUnited Kingdom, New Zealand
-
Arrow TherapeuticsDDS, Dundee; David Mutimer, Birmingham; Ed Gane, ACS New ZealandTerminatedChronic Hepatitis CNew Zealand, United Kingdom
-
Valneva Austria GmbHCompletedSARS-CoV-2 InfectionNew Zealand, Netherlands
-
NovartisNovartis PharmaceuticalsCompletedHepatitis BHong Kong, Singapore, New Zealand
-
University of RochesterCompleted
-
Soroka University Medical CenterEiger BioPharmaceuticalsActive, not recruitingHepatitis D, ChronicIsrael, New Zealand, Turkey
-
Merck Sharp & Dohme LLCCompletedBacterial ConjunctivitisUnited States
-
Trek Therapeutics, PBCCompletedChronic Hepatitis C | Hepatitis C Genotype 1 | Hepatitis C (HCV) | Hepatitis C Viral InfectionUnited States, New Zealand
-
Gilead SciencesCompletedChronic Hepatitis BUnited States, New Zealand
-
Hoffmann-La RocheCompletedHepatitis C, ChronicNew Zealand, Poland, France
-
Hoffmann-La RocheCompletedHepatitis C, ChronicNew Zealand, Australia